XML 16 R6.htm IDEA: XBRL DOCUMENT v3.19.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
Public Offering [Member]
COMMON SHARES
Public Offering [Member]
At The Market [Member]
COMMON SHARES
At The Market [Member]
COMMON SHARES
ACCUMULATED DEFICIT
ACCUMULATED OTHER COMPREHENSIVE INCOME/(LOSS)
Total
Balance at Dec. 31, 2017         $ 273,210,907 $ (240,262,376) $ (35,383) $ 32,913,148
Balance (in shares) at Dec. 31, 2017         51,768,424      
Increase (Decrease) in Shareholders' Equity                
Net Loss           (17,780,313)   (17,780,313)
Unrealized Loss on Available-for-Sale Investments             (47,542) (47,542)
Foreign Currency Translation Adjustments             (7,389) (7,389)
Stock-based compensation         $ 1,811,335     1,811,335
Balance at Jun. 30, 2018         $ 275,022,242 (258,042,689) (90,314) 16,889,239
Balance (in shares) at Jun. 30, 2018         51,768,424      
Balance at Mar. 31, 2018         $ 273,656,910 (245,811,897) (227,863) 27,617,150
Balance (in shares) at Mar. 31, 2018         51,768,424      
Increase (Decrease) in Shareholders' Equity                
Net Loss           (12,230,792)   (12,230,792)
Unrealized Loss on Available-for-Sale Investments             142,454 142,454
Foreign Currency Translation Adjustments             (4,905) (4,905)
Stock-based compensation         $ 1,365,332     1,365,332
Balance at Jun. 30, 2018         $ 275,022,242 (258,042,689) (90,314) 16,889,239
Balance (in shares) at Jun. 30, 2018         51,768,424      
Balance at Dec. 31, 2018         $ 299,601,960 (272,388,234) 63,148 $ 27,276,874
Balance (in shares) at Dec. 31, 2018         57,034,154     57,034,154
Increase (Decrease) in Shareholders' Equity                
Net Loss           (18,970,530)   $ (18,970,530)
Unrealized Loss on Available-for-Sale Investments             4,265 4,265
Foreign Currency Translation Adjustments             144 144
Exercise of Employee Stock Option         $ 147,900     $ 147,900
Exercise of Employee Stock Option (in shares)         30,000     30,000
Delivery of common stock underlying restricted stock units, net of tax         $ (95,429)     $ (95,429)
Delivery of common stock underlying restricted stock units, net of tax (in shares)         64,173      
Issuance of Common Shares $ 16,120,679 $ 16,120,679 $ 2,089,208 $ 2,089,208        
Issuance of Common Shares (in shares) 5,833,334   437,043          
Stock-based compensation         $ 3,018,628     3,018,628
Balance at Jun. 30, 2019         $ 320,882,946 (291,358,764) 67,557 $ 29,591,739
Balance (in shares) at Jun. 30, 2019         63,398,704     63,398,704
Balance at Mar. 31, 2019         $ 301,171,733 (281,066,581) 55,895 $ 20,161,047
Balance (in shares) at Mar. 31, 2019         57,128,327      
Increase (Decrease) in Shareholders' Equity                
Net Loss           (10,292,183)   (10,292,183)
Unrealized Loss on Available-for-Sale Investments             11,426 11,426
Foreign Currency Translation Adjustments             236 236
Issuance of Common Shares $ 16,120,679 $ 16,120,679 $ 2,089,208 $ 2,089,208        
Issuance of Common Shares (in shares) 5,833,334   437,043          
Stock-based compensation         $ 1,501,326     1,501,326
Balance at Jun. 30, 2019         $ 320,882,946 $ (291,358,764) $ 67,557 $ 29,591,739
Balance (in shares) at Jun. 30, 2019         63,398,704     63,398,704